Przyszłość medycyny według pisma Nature: terapia genowa w chorobach sercowo-naczyniowych

Anthony King. The heart-disease vaccine Advances in gene editing raise the prospect of a one-off injection that could reduce the risk of cardiovascular disease. Nature Outlook 2018;555:S23 (dostępny pełen tekst)

Consider this scenario: it’s 2037, and a middle-aged person can walk into a health centre to get a vaccination against cardiovascular disease. The injection targets cells in the liver, tweaking a gene that is involved in regulating cholesterol in the blood. The simple procedure trims cholesterol levels and dramatically reduces the person’s risk of a heart attack …
Nature Outlook, marzec 2018